U.S. pharma large copyright scrapped two experimental weight loss supplements final calendar year—a as soon as-day-to-day tablet, lotiglipron, as a result of elevated liver enzymes in addition to a 2 times-daily pill, danuglipron, as a consequence of powerful Unwanted side effects—but CEO Albert Bourla has said the company is set to “Particip